Sarcopenic Obesity among the Elderly: Bridging Nutrition Gaps
Abstract
The global demographic shift toward an ageing population has brought sarcopenic obesity, the coexistence of age-related muscle loss and excess adiposity into sharp clinical focus. Affecting approximately 5-10% of older adults, the dual burden subsequently leads to metabolic, functional, and mortality outcomes than either sarcopenia or obesity alone.1 Yet despite growing recognition, significant nutrition gaps persist in both diagnosis and management. The article tries to explore the nutritional challenges inherent to sarcopenic obesity and suggests a multi-pronged approach to address these gaps.
How to cite this article:
Raja D. Sarcopenic Obesity among the Elderly: Bridging Nutrition Gaps. Chettinad Health CityMed J. 2026;15(1):1-3
DOI: https://doi.org/10.24321/2278.2044.202601
References
Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.
Nature Reviews Endocrinology. 2018 Sep;14(9):513-37.
Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer JM, Boirie
Y, Cruz-Jentoft AJ, Dicker D, Frara S. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and
EASO consensus statement. Obesity facts. 2022 May 17;15(3):321-35.
Barazzoni R, Bischoff S, Boirie Y, Busetto L, Cederholm T, Dicker D, Toplak H, Van Gossum A, Yumuk V, Vettor
R. Sarcopenic obesity: time to meet the challenge. Obesity facts. 2018 Jul 18;11(4):294-305.
Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A, Cederholm T, Cruz-Jentoft A, Krznariç
Z, Nair KS, Singer P. Protein intake and exercise for optimal muscle function with aging: recommendations
from the ESPEN Expert Group. Clinical nutrition. 2014 Dec 1;33(6):929-36.
Bouchonville MF, Villareal DT. Sarcopenic obesity: how do we treat it?. Current opinion in endocrinology,
diabetes and obesity. 2013 Oct 1;20(5):412-9.
